HSPB7 Deficiency Drives Aortic Aneurysm Progression in Marfan Syndrome Through Vascular Smooth Muscle Cell Phenotypic

Zining An1, Tao Yan2, Yang Ming2

  • 1Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Insights

Marfan syndrome (Mfs) involves thoracic aortic aneurysm (TAA) linked to FBN1 mutations. This study reveals HSPB7

Area of Science:

  • Cardiovascular Biology
  • Genetics
  • Cell Biology

Background:

  • Marfan syndrome (Mfs), caused by FBN1 mutations, leads to thoracic aortic aneurysm (TAA) due to vascular smooth muscle cell (VSMC) dysfunction.
  • The specific role of heat shock protein beta 7 (HSPB7) in Mfs-associated TAA pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying Mfs-associated TAA using patient-derived cells.
  • To explore the function of HSPB7 in VSMC behavior within the context of Mfs-TAA.

Main Methods:

  • Integrated multi-omics analysis of induced pluripotent stem cell (hiPSC)-derived VSMCs from Mfs patients.
  • Analysis of intercellular communication, cellular proportions, and pathway alterations.
  • Investigating the effect of HSPB7 modulation (downregulation and overexpression) on VSMC phenotype.

Main Results:

  • Identified immune cell infiltration, reduced VSMC proportion, and altered intercellular communication in Mfs-TAA.
  • Observed dysregulation in cell adhesion, extracellular matrix (ECM) remodeling, immune signaling, and metabolic pathways.
  • Found that HSPB7 downregulation correlates with impaired VSMC proliferation, migration, and metabolism; HSPB7 overexpression ameliorated these pathological features.

Conclusions:

  • Mfs-TAA pathogenesis involves structural, immune, and metabolic imbalances.
  • HSPB7 plays a regulatory role in VSMC phenotypic modulation in Mfs-TAA.
  • Restoring HSPB7 levels may offer a therapeutic strategy for Mfs-TAA by improving VSMC function.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...